We believe that knowing research methods is not only needed to develop your own study, but serves as the basis for understanding strengths and limitations of medical information and for improving patient care. Learn how its done, learn how it works.
Pablo Lamelas –PROTECTED TAVR study was presented in TCT 2022, bringing more discussion than ever for the use of Sentinel (cerebral embolic protection, CEP) during TAVR procedures. Many key opinion … Continue reading If you think PROTECTED TAVR is a NEGATIVE trial, you should read this: Cerebral protection (Sentinel) in TAVI
Pablo Lamelas – Last Thursday June 24th the first SOLACI/SIAC joint guideline was presented at ICBA Instituto Cardiovascular Rounds. Here we present a summary in English with outstanding faculty, an … Continue reading SOLACI/SIAC 2021 Guideline on the use of TAVI vs SAVR in Latin America: Presentation at ICBA Grand Rounds.
by Fernando Botto, MD, MSc During 2020, most research was focused on powerful and modern anti-inflammatory drugs, unfortunately expensive and not widely available for everyone. Colchicine is a cheap and … Continue reading COLCORONA: a challenging viewpoint
Pablo Lamelas – In the last decades multiple trials comparing the efficacy of PCI vs CABG incorporated repeat revascularization in the primary composite outcome, which favoured CABG repeatedly, and frequently … Continue reading Readdressing the validity of Repeat Revascularization outcome in PCI vs CABG trials
Fernando Botto – A general rule dictates “the more the antithombotic effect, the higher the risk of bleeding”. In stable CAD patients beyond 1 year of PCI or without prior … Continue reading NOACs in stable CAD with Atrial Fibrillation: with or without aspirin? The AFIRE trial